Racker Cell Biology and Immunology of Leukocyte Function

1. Auflage 2012
ISBN: 978-0-323-14186-4
Verlag: Elsevier Science & Techn.
Format: EPUB
Kopierschutz: 6 - ePub Watermark

E-Book, Englisch, 990 Seiten

Cell Biology and Immunology of Leukocyte Function is a collection of papers presented at the 12th International Leukocyte Culture Conference, held in Beersheba, Israel on June 1978. This book is organized into seven parts encompassing 111 chapters. The contributors cover the different aspects of cell biology and immunology and the unique leukocyte function. Part I describes the mechanism of lymphocyte activation, the structure and function of the plasma membrane, and the macromolecular synthesis during lymphocyte activation. This part also deals with the interaction of lymphocytes with mitogenic lectins, the comparison of the mitogenic and nonmitogenic lectin binding, and the role of macrophages in the response of lymphocytes to lectins. Part II explores the thymic factors and the development of characteristic markers, antigens, and receptors. This part particularly emphasizes lymphocyte differentiation. Parts III and IV examine the genetic control and intercellular interactions involved in leukocyte function and the parameters of the immune response under in vitro conditions. Chapters on cytotoxicity, the mechanisms of phagocytic killing, autoimmunity, and the responses of leukocytes to tumor cells are included in these parts. Part V discusses the interactions of viruses and leukocytes and provides data on the physical mapping and analysis of sarcoma and leukemia viruses, while Part VI considers the application of leukocyte culture to problems of clinical medicine. Part VII involves the study of radiation effects, with an emphasis on the application of total lymphoid irradiation to the induction of transplantation tolerance. This part also looks into the role of the DNA repair process. Cell biologists, immunologists, and biomedical scientists and researchers will greatly benefit from this book.

Autoren/Hrsg.

Racker, Efraim

Leseproben

Participants

.

R.K. Aaran,     University of Tampare, Tampare, Finland

A. Adam,     Institut de Biochemie, Universite du Paris Sud, Orsay, France

E. Ades,     University of Alabama, Birmingham, Alabama

M. Aker,     Hebrew University Hadassah Medical School, Jerusalem, Israel

R. Aksamit,     National Institute of Health, Bethesda, Maryland

P. Alexander,     Royal Cancer Hospital, Belmont, England

J.P. Allison,     Scripps Clinic and Research Foundation, La Jolla, California

R.N. Apte,     Bar Ilan University, Ramat Gan, Israel

D. Armerding,     Sandoz Forschungsinstitut, Vienna, Austria

R.F. Ashman,     UCLA School of Medicine, Los Angeles, California

A. Astaldi,     Central Laboratory of the Netherlands Red Cross, Amsterdam, The Netherlands

G.C.B. Astaldi,     Central Laboratory of the Netherlands Red Cross, Amsterdam, The Netherlands

W. Augener,     University of Essen, West Germany

R. Averdunk,     Freie Universitat Berlin, West Germany

B. Axelsson,     University of Stockholm, Stockholm, Sweden

F.H. Bach,     Immunobiology Research Center, Madison, Wisconsin

J.F. Bach,     Hopital Necker, Paris, France

M.A. Bach,     Hopital Necker, Paris, France

W.W. Bakker,     University of Groningen, Groningen, The Netherlands

J.J. Ballet,     Hopital des Enfanct-Malades, Paris, France

Y. Barak,     Kaplan Hospital, Rehovot, Israel

R.F. Barth,     Mount Sinai Medical Center, Milwaukee, Wisconsin

J.R. Battisto,     Cleveland Clinic Foundation, Cleveland, Ohio

M. Becker,     Meir Hospital, Kfar Saba, Israel

C. Bell,     Karolinska Institute, Stockholm, Sweden

D. Belpomme,     Institut de Cancerologie et d’Immunogenetique, Hopital Paul Brousse, Villejuif, France

S. Ben-Ami,     Weizmann Institute of Science, Rehovot, Israel

S. Ben-Efraim,     Tel Aviv University, Ramat Aviv, Israel

Y. Ben Neriah,     Weizmann Institute of Science, Rehovot, Israel

Z. Bentwich,     Kaplan Hospital, Rehovot, Israel

S.L. Berger,     National Cancer Institute, N.I.H. Bethesda, Maryland

B. Bergholtz,     National Hospital of Norway, Oslo, Norway

G. Berke,     Weizmann Institute of Science, Rehovot, Israel

J. Bernheim,     Vrije Universiteit Brussel, Jules Bordet Institute, Brussels, Belgium

W. Bessler,     Institute of Microbiology, University of Tubingen, Germany

M. Biniaminov,     Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel

E. Blitzstein-Willinger,     Freie Universitat Berlin, Germany

F. Blomberg,     Pharmacia Diagnostica AB, Uppsala, Sweden

R.P. Blumenthal,     N.I.H., Bethesda, Maryland

W. Boersma,     Radiobiological Institute TNO, Rijswijk, The Netherlands

R.L.H. Bolhuis,     Rotterdam Radio–Therapy Institute, Rijswijk, The Netherlands

G. Boltz-Nitulescu,     Institute of General and Experimental Pathology, University of Vienna, Austria

C. Bona,     National Cancer Institute, N.I.H., Bethesda, Maryland

B. Bonavida,     UCLA School of Medicine, Los Angeles, California

G.D. Bonnard,     National Cancer Institute, N.I.H., Bethesda, Maryland

B.A. Bradley,     University Hospital Bloodbank, Leiden, The Netherlands

S. Bright,     University of Cambridge, Cambridge, London, England

A. Castellani,     Atomic Energy Commission, Casaccia, Rome, Italy

R. Cesla,     Weizmann Institute of Science, Rehovot, Israel

J. Charreire,     Hopital Necker, Paris, France

F. Chattah,     Soroka Medical Center, Beer Sheva, Israel

J.W. Chiao,     Memorial Sloan-Kettering Institute, New York

J. Clot,     Hospital St. Eloi, Montpelier, France

J.D. Clough,     Cleveland Clinic Foundation, Cleveland, Ohio

D. Cohen,     Ben Gurion University of the Negev, Beer Sheva, Israel

I.R. Cohen,     Weizmann Institute of Science, Rehovot, Israel

M. Cohen,     Tel Hasomer Hospital, Ramat Gan, Israel

D-A. Cohn,     York College, Jamaica, New York

K.M. Connolly,     Virginia Polytechnic Institute, Blacksburg, Virginia

D.A. Cooper,     St. Vincent’s Hospital, Sydney, Australia

H.L. Cooper,     N.E.I. National Institute of Health, Bethesda, Maryland

G. Cordier,     Hopital Edourd Herriot, Lyon, France

J. Couderc,     Institut d’Immunobiologie, Hopital Broussais, Paris, France

C. Cowing,     National Cancer Institute, N.I.H., Bethesda, Maryland

A.S. Cross,     Walter Reed Army Institute of Research, Washington,...